Results 71 to 80 of about 7,956,506 (236)

Functional Dissociation Between Cervical VEMP and Posterior Canal vHIT in 1770 Unselected Ears

open access: yesThe Laryngoscope, EarlyView.
Cervical VEMP and posterior canal vHIT are conventionally treated as measures of a single inferior vestibular unit. In 1770 unselected ears from a diagnosis‐agnostic registry, the two tests disagreed in 72.7% of ears abnormal on at least one test, with chance‐corrected agreement near zero (κ = 0.097) and unchanged across age strata.
Fumiyuki Goto   +2 more
wiley   +1 more source

ONTT (Optic Neuritis Treatment Trial) Update

open access: yes, 2001
The Optic Neuritis Treatment Trial (ONIT), in many ways, has distinguished neuro-ophthalmology by setting the tenor of clinical trials in the disciplines of neuroophthalmology and Multiple Sclerosis research.
Craig H. Smith, MD
core  

Big Data Analysis of Inflammatory Conditions Associated With Optic Neuritis

open access: yes, 2021
The optic neuritis treatment trial was a prospective randomized control trial that established multiple sclerosis as the most common cause of optic neuritis up to 50%.
Andrew Carey
core  

Therapy of NMO spectrum disorders

open access: yesAnnals of Indian Academy of Neurology, 2015
Neuromyelitis optica (NMO) is an autoimmune demyelinating condition of the central nervous system often associated with aquaporin-4 (AQP4) autoantibodies manifesting as severe optic neuritis and long segment myelitis with tendency to relapse ...
Atanu Biswas, Arabinda Mukherjee
doaj   +1 more source

Factors Associated With Bilateral Involvement in Non‐Infectious Labyrinthitis: A Case–Control Study

open access: yesThe Laryngoscope, EarlyView.
Non‐infectious labyrinthitis may progress from unilateral to bilateral inner‐ear involvement, resulting in greater functional impairment. In this retrospective case–control study of 50 patients, younger age, female sex, and the presence of systemic disease were associated with bilateral involvement. These exploratory findings may help identify patients
Douglas Henderson   +9 more
wiley   +1 more source

Visual Field Abnormalities 10 Years After Optic Neuritis: Experience in the Optic Neuritis Treatment Trial (ONTT)

open access: yes, 2007
To evaluate visual field abnormalities 1- 5 and 10 years after the Optic Neuritis Treatment Trial (ONTT).IC-H3fi-optic-neuritis-treatment ...
John Keltner; Chris Johnson; Kimberly Cello; Robin Gal; Andrea Kalajian; Craig Kollman; Roy Beck; Optic Neuritis Study Group
core  

FEATURES OF THE CLINICAL MANIFESTATIONS OF AUTOIMMUNE OPTIC NEUROPATHY IN MULTIPLE SCLEROSIS ON CORTICOSTEROID THERAPY

open access: yesMajalah Biomorfologi
Highlights • Intravenous corticosteroid treatment followed by oral clinical treatment can reduce the incidence of post-treatment optic neuritis recurrenc • Visual acquisition increases at one-month post-treatment.
Dalia Sharliz Raihana   +2 more
doaj   +1 more source

p‐Brain: A Modular Open‐Source Framework for Automated Quantitative DCE‐MRI of Cerebral Perfusion, Microvasculature, and Blood–Brain Barrier Permeability

open access: yesMagnetic Resonance in Medicine, EarlyView.
ABSTRACT We present p‐Brain, a modular, open‐source framework for reproducible, automated quantitative DCE‐MRI at scale. Rather than a fixed pipeline, p‐Brain is built from interchangeable stages (ingestion, T1/M0$$ {T}_1/{M}_0 $$ fitting, vascular and tissue ROI extraction, signal‐to‐concentration conversion, kinetic modeling, and quality control ...
Edis D. Tireli   +5 more
wiley   +1 more source

The immunological landscape of the area postrema in neuromyelitis optica spectrum disorders

open access: yesBrain Pathology, EarlyView.
Aquaporin‐4 antibody‐positive neuromyelitis spectrum disorder is characterized by large tissue destructive lesions in medulla, spinal cord, and optic nerves, with only partial recovery from clinical symptoms, and by lesions with very little tissue destruction and mostly complete recovery from clinical symptoms, as seen in the area postrema ...
Qian Yu   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy